These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11837458)

  • 21. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase.
    Schallreuter KU; Moore J; Wood JM; Beazley WD; Gaze DC; Tobin DJ; Marshall HS; Panske A; Panzig E; Hibberts NA
    J Investig Dermatol Symp Proc; 1999 Sep; 4(1):91-6. PubMed ID: 10537016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic association study of polymorphisms in the catalase gene with the risk of osteonecrosis of the femoral head in the Korean population.
    Kim TH; Hong JM; Oh B; Cho YS; Lee JY; Kim HL; Shin ES; Lee JE; Park EK; Kim SY
    Osteoarthritis Cartilage; 2008 Sep; 16(9):1060-6. PubMed ID: 18353692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low catalase levels in the epidermis of patients with vitiligo.
    Schallreuter KU; Wood JM; Berger J
    J Invest Dermatol; 1991 Dec; 97(6):1081-5. PubMed ID: 1748819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human catalase, its polymorphisms, regulation and changes of its activity in different diseases.
    Kodydková J; Vávrová L; Kocík M; Žák A
    Folia Biol (Praha); 2014; 60(4):153-67. PubMed ID: 25152049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of ACE gene I/D polymorphism with vitiligo: a meta-analysis.
    Lv Y; Lv Y; Li Q; Lei W; Luan Q; Gao T
    Arch Dermatol Res; 2013 Jul; 305(5):365-70. PubMed ID: 23325447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTPN22 is genetically associated with risk of generalized vitiligo, but CTLA4 is not.
    LaBerge GS; Bennett DC; Fain PR; Spritz RA
    J Invest Dermatol; 2008 Jul; 128(7):1757-62. PubMed ID: 18200060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Angiotensin-Converting Enzyme ACE Gene Polymorphism with ACE Activity and Susceptibility to Vitiligo in Egyptian Population.
    Badran DI; Nada H; Hassan R
    Genet Test Mol Biomarkers; 2015 May; 19(5):258-63. PubMed ID: 25807210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin.
    Sravani PV; Babu NK; Gopal KV; Rao GR; Rao AR; Moorthy B; Rao TR
    Indian J Dermatol Venereol Leprol; 2009; 75(3):268-71. PubMed ID: 19439879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of catalase C262T gene polymorphism in susceptibility to ovarian cancer in Kermanshah province, Western Iran.
    Moradi MT; Khazaei M; Khazaei M
    J Obstet Gynaecol; 2018 May; 38(4):562-566. PubMed ID: 29421935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of elevated homocysteine levels and Methylenetetrahydrofolate reductase (MTHFR) 1298 A > C polymorphism with Vitiligo susceptibility in Gujarat.
    Jadeja SD; Mansuri MS; Singh M; Patel H; Marfatia YS; Begum R
    J Dermatol Sci; 2018 May; 90(2):112-122. PubMed ID: 29395581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo.
    Yazici AC; Erdal ME; Kaya TI; Ikizoglu G; Savasoglu K; Camdeviren H; Tursen U
    Arch Dermatol Res; 2006 Jun; 298(1):46-9. PubMed ID: 16691430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome 11p13) in a Russian population.
    Chistiakov DA; Savost'anov KV; Turakulov RI; Titovich EV; Zilberman LI; Kuraeva TL; Dedov II; Nosikov VV
    Diabetes Metab Res Rev; 2004; 20(3):219-24. PubMed ID: 15133753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variants of the DDR1 gene are associated with vitiligo in two independent Brazilian population samples.
    Silva de Castro CC; do Nascimento LM; Walker G; Werneck RI; Nogoceke E; Mira MT
    J Invest Dermatol; 2010 Jul; 130(7):1813-8. PubMed ID: 20182441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of UVRAG polymorphisms with susceptibility to non-segmental vitiligo in a Korean sample.
    Jeong TJ; Shin MK; Uhm YK; Kim HJ; Chung JH; Lee MH
    Exp Dermatol; 2010 Aug; 19(8):e323-5. PubMed ID: 20163458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of FOXP3 (rs3761548) promoter polymorphism with nondermatomal vitiligo: A study from India.
    Jahan P; Cheruvu R; Tippisetty S; Komaravalli PL; Valluri V; Ishaq M
    J Am Acad Dermatol; 2013 Aug; 69(2):262-6. PubMed ID: 23498308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association and expression of the antigen-processing gene PSMB8, coding for low-molecular-mass protease 7, with vitiligo in North India: case-control study.
    Dani P; Patnaik N; Singh A; Jaiswal A; Agrawal B; Kumar AA; Varkhande SR; Sharma A; Vaish U; Ghosh P; Sharma VK; Sharma P; Verma G; Kar HK; Gupta S; Natarajan VT; Gokhale RS; Rani R
    Br J Dermatol; 2018 Feb; 178(2):482-491. PubMed ID: 28207947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genetic concept of vitiligo.
    Zhang XJ; Chen JJ; Liu JB
    J Dermatol Sci; 2005 Sep; 39(3):137-46. PubMed ID: 16140217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermal oxidative stress in vitiligo.
    Passi S; Grandinetti M; Maggio F; Stancato A; De Luca C
    Pigment Cell Res; 1998 Apr; 11(2):81-5. PubMed ID: 9585244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients.
    Jin SY; Park HH; Li GZ; Lee HJ; Hong MS; Park HJ; Park HK; Seo JC; Yim SV; Chung JH; Lee MH
    J Dermatol Sci; 2004 Sep; 35(3):181-6. PubMed ID: 15381239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.